HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fong, L. G. Articles by Hom, S. E. Search for Related Content PubMed PubMed Citation Articles by Fong, L. G. Articles by Hom, S. E. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 35, 893-904, Copyright © 1994 by Lipid Research, Inc.

ARTICLES

Inhibition of the macrophage-induced oxidation of low density lipoprotein by interferon-gamma

LG Fong, TS Albert and SE Hom
Research Institute, Palo Alto Medical Foundation, CA 94301.

The regulation of the macrophage-induced oxidation of low density lipoprotein (LDL) by cytokines was investigated. As an initial source of cytokines, medium from an activated type 2 helper T-cell clone was tested. This cell-free supernatant inhibited the subsequent oxidation of LDL by mouse peritoneal macrophages. The inhibition was concentration- and time-dependent as measured by changes in thiobarbituric acid (TBA) reactive substances. In addition, there were decreases in conjugated diene formation as well as the generation of LDL particles with an increased net negative charge that were recognized by the scavenger receptor. The inhibition was not due to a decrease in cell viability or to nonspecific antioxidant activity, as assessed by measuring phagocytic activity and metal ion-induced oxidation of LDL, respectively. Using antibodies that inactivate specific cytokines, the role of select individual cytokines in this inhibition was investigated. Addition of antibodies against interleukin- 3 (IL-3), granulocyte/macrophage-colony stimulating factor (GM-CSF), or tumor necrosis factor alpha (TNF alpha) to the media had little or no effect on the ability of the cytokines to affect oxidation by macrophages, whereas anti-interferon-gamma (IFN-gamma) antibodies completely reversed the inhibition induced by the T-cell supernatant. A role for this cytokine was confirmed using recombinant IFN-gamma. A concentration-dependent inhibition was produced with a maximum inhibition to 24% of control cells, whereas smooth muscle cell- dependent LDL oxidation was not affected. To examine the cellular basis for the inhibition, the effect of IFN-gamma on oxidant activities (O2- production, lipoxygenase activity, and thiol production) were measured. IFN-gamma at concentrations that maximally inhibit LDL oxidation stimulated the phorbol myristate acetate (PMA)-induced production of O2- 1.4-times greater than control cells after one hour. Similarly, thiol production was increased 29% by IFN-gamma pretreatment. In contrast, macrophage lipoxygenase was inhibited approximately 21%. Based on these in vitro findings, the potential regulation of macrophage LDL oxidation by IFN-gamma in vivo was also investigated. Macrophages from Toxoplasma gondii-infected mice have been shown previously to be activated in situ by an IFN-gamma-dependent mechanism. These were tested for their ability to oxidize LDL. Macrophages from these mice oxidized LDL to a much lesser extent than cells from age-matched control mice, demonstrating that the ability of macrophages to oxidize lipoprotein may also be susceptible to regulation possibly also by IFN-gamma in vivo. Together these studies demonstrate that the cell-mediated oxidation of LDL can be regulated by cytokines, specifically IFN-gamma. This mode of regulation may play a role in regulating this process in the developing atherosclerotic lesion.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. Tedgui and Z. Mallat Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways Physiol Rev, April 1, 2006; 86(2): 515 - 581. [Abstract] [Full Text] [PDF]

				I. Sethy-Coraci, L. W. Crock, and S. C. Silverstein PAF-receptor antagonists, lovastatin, and the PTK inhibitor genistein inhibit H2O2 secretion by macrophages cultured on oxidized-LDL matrices J. Leukoc. Biol., November 1, 2005; 78(5): 1166 - 1174. [Abstract] [Full Text] [PDF]

				A. Daugherty, N. R. Webb, D. L. Rateri, and V. L. King Thematic review series: The Immune System and Atherogenesis. Cytokine regulation of macrophage functions in atherogenesis J. Lipid Res., September 1, 2005; 46(9): 1812 - 1822. [Abstract] [Full Text] [PDF]

				E. J. Harvey and D. P. Ramji Interferon-{gamma} and atherosclerosis: Pro- or anti-atherogenic? Cardiovasc Res, July 1, 2005; 67(1): 11 - 20. [Abstract] [Full Text] [PDF]

				T. R. Hughes, T. S. Tengku-Muhammad, S. A. Irvine, and D. P. Ramji A Novel Role of Sp1 and Sp3 in the Interferon-gamma -mediated Suppression of Macrophage Lipoprotein Lipase Gene Transcription J. Biol. Chem., March 22, 2002; 277(13): 11097 - 11106. [Abstract] [Full Text] [PDF]

				P. M. Morganelli, S. M. Kennedy, and T. I. Mitchell Differential effects of interferon-{gamma} on metabolism of lipoprotein immune complexes mediated by specific human macrophage Fc{gamma} receptors J. Lipid Res., March 1, 2000; 41(3): 405 - 415. [Abstract] [Full Text]

				G. M. Chisolm III, S. L. Hazen, P. L. Fox, and M. K. Cathcart The Oxidation of Lipoproteins by Monocytes-Macrophages. BIOCHEMICAL AND BIOLOGICAL MECHANISMS J. Biol. Chem., September 10, 1999; 274(37): 25959 - 25962. [Full Text] [PDF]

				S. M. Sendobry, J. A. Cornicelli, K. Welch, M. J. Grusby, and A. Daugherty Absence of T Lymphocyte-Derived Cytokines Fails to Diminish Macrophage 12/15-Lipoxygenase Expression In Vivo J. Immunol., August 1, 1998; 161(3): 1477 - 1482. [Abstract] [Full Text] [PDF]

				V. A. Folcik, R. Aamir, and M. K. Cathcart Cytokine Modulation of LDL Oxidation by Activated Human Monocytes Arterioscler. Thromb. Vasc. Biol., October 1, 1997; 17(10): 1954 - 1961. [Abstract] [Full Text]